KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Receivables (2017 - 2026)

Alnylam Pharmaceuticals (ALNY) has disclosed Change in Receivables for 18 consecutive years, with $110.4 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables rose 1385.35% year-over-year to $110.4 million; the TTM value through Mar 2026 reached $463.0 million, up 390.44%, while the annual FY2025 figure was $360.0 million, 315.9% up from the prior year.
  • Change in Receivables hit $110.4 million in Q1 2026 for Alnylam Pharmaceuticals, up from -$184.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $399.9 million in Q3 2025 and bottomed at -$184.2 million in Q4 2025.
  • Average Change in Receivables over 5 years is $40.6 million, with a median of $7.4 million recorded in 2025.
  • Year-over-year, Change in Receivables tumbled 470.68% in 2022 and then surged 1913.17% in 2025.
  • Alnylam Pharmaceuticals' Change in Receivables stood at $53.3 million in 2022, then crashed by 107.26% to -$3.9 million in 2023, then soared by 1638.07% to $59.5 million in 2024, then plummeted by 409.62% to -$184.2 million in 2025, then soared by 159.93% to $110.4 million in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at $110.4 million, -$184.2 million, and $399.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.